35
American Heart Association. Diabetes Care. 2009;32:187 192.
9.
The effect of intensive treatment of diabetes on the development and pro-
gression of long-term complications in insulin-dependent diabetes melli-
tus. The diabetes control and complications trial research group. N Engl J
Med. 1993;329: 977-86.
10.
Tight blood pressure control and risk of macrovascular and microvascular
complications in type 2 diabetes: UKPDS 38. UK prospective diabetes
study group. BMJ. 1998;317:703-13.
11.
Klein R, Klein BE, Moss SE, Davis MD, Demets DL. The wisconsin epide-
miologic study of diabetic retinopathy. II. Prevalence and risk of diabetic
retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol.
1984;102: 520-6.
12.
Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, Chantry K, et al.
Association of elevated serum lipid levels with retinal hard exudate in
diabetic retinopathy early treatment diabetic retinopathy study (ETDRS)
report 22. Arch Ophthalmol. 1996;114:1079 1084.
13.
Gordon B, Chang S,Kavanagh M, BerrocalM,Yannuzzi L, Robertson C, et
al. The effects of lipid lowering on diabetic retinopathy. Am J Ophthalmol.
1991;112: 385-391.
14.
Effect of intensive blood-glucose control with metformin on complica-
tions in overweight patients with type 2 diabetes (UKPDS 34). UK Pros-
pective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854-65.
15.
Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macro-
vascular complications in diabetes? the wisconsin epidemiologic study of
diabetic retinopathy. Arch Intern Med. 1997;157:650-6.
16.
Boelter MC, Gross JL, Canani LH, et al. Proliferative diabetic retinopathy
is associated with microalbuminuria in patients with type 2 diabetes. Braz
J Med Biol Res. 2006;39:1033-9.
17.
Berman DH, Friedman EA. Partial absorption of hard exudates in patients
with diabetic end stage renal disease and severe anemia after treatment
with erythropoietin. Retina. 1994;14:1 5.
18.
Friedman EA, Brown CD, Berman DH. Erythropoietin in diabetic macular
edema and renal insufficiency. Am J Kidney Dis. 1995;26:202 208.
19.
Leitao CB, Canani LH, Scheffel R, et al. Smoking and diabetes chronic
complications. Diabetes. 2005;Supp 1:A205-05.
20.
Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. Risks
of progression of retinopathy and vision loss related to tight blood pres-
sure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol.
2004;122:1631-40.
21.
Klein R, Klein BE, Moss SE, Davis MD, Demets DL. The wisconsin epi-
demiologic study of diabetic retinopathy. IX. Four-year incidence and
progression of diabetic retinopathy when age at diagnosis is less than 30
years. Arch Ophthalmol. 1989;107:237-43.
22.
Effect of pregnancy on microvascular complications in the diabetes con-
trol and complications trial. the diabetes control and complications trial
research group. Diabetes Care. 2000;23:1084-91.